In vitro characterization and in vivo release profile of a poly (d,l-lactide-co-glycolide)-based implant delivery system for the α-MSH analog, melanotan-I-Reference-Cited by-同舟云学术

In vitro characterization and in vivo release profile of a poly (d,l-lactide-co-glycolide)-based implant delivery system for the α-MSH analog, melanotan-I

Published:1998-08 Issue:1 Volume:170 Page:109-117
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Bhardwaj R.,Blanchard J.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference21 articles.

1. In vitro evaluation of poly(dl-lactide-co-glycolide) polymer-based implants containing the α-melanocyte stimulating hormone analog, Melanotan-I;Bhardwaj;J. Control. Release,1997

2. Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems;Bodmer;J. Control. Release,1992

3. Melanotropin bioassays: in vitro and in vivo comparisons;Castrucci;Gen. Comp. Endocrinol.,1984

4. Discovery and development of Goserelin (Zoladex®);Dutta;Pharm. Med.,1993

5. A biodegradable delivery system for peptides: preclinical experience with the gonadotrophin-releasing hormone agonist Zoladex®;Furr;J. Control. Release,1992

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advancements in additive manufacturing techniques employed in the pharmaceutical industry: A bird's eye view;Annals of 3D Printed Medicine;2022-10

2. Continuous twin screw granulation – An advanced alternative granulation technology for use in the pharmaceutical industry;International Journal of Pharmaceutics;2020-04

3. Biodegradation of 3D‐printed polylactic acid milliprojections under physiological conditions;Journal of Applied Polymer Science;2020-02-17

4. Pharmacogenomic phase transition from personalized medicine to patient-centric customized delivery;The Pharmacogenomics Journal;2019-12-10

5. Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders;Clinical Pharmacokinetics;2017-01-06